Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Tunis Med ; 101(8-9): 709-714, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-38445407

RESUMEN

INTRODUCTION: The worldwide obesity epidemic continues unabated. Obesity and its associated health risks are considered as the major causes of morbidity and mortality. Currently, bariatric surgery is the most effective treatment for people with severe obesity resulting in sustainable weight loss and a reduced risk for co-morbidities. Sleeve gastrectomy is the most common bariatric procedure undertaken in Tunisia. AIM: we aim to evaluate the vitamin status of the obese patients before and after sleeve gastrectomy. METHODS: Thirty obese patients undergoing sleeve gastrectomy, were recruited from Obesity unit. In this study. A biological assessment was performed pre-operatively and controlled 6 months following the sleeve gastrectomy including: calcemia, parathyroid hormone (PTH), albuminemia and dosage of vitamin D, vitamin B9 and vitamin B12. RESULTS: Six months post sleeve gastrectomy, vitamin deficiencies were more prevalent: the mean level of vitamin B9, vitamin B12 and vitamin D respectively, has decreased from 5.03±3.28 ng / ml to 2.71±1.52 ng / ml, from 348.06±158.92 pg/ml to 264.62±119.77 pg/ml and from 17.18±11.45 ng/ml to 11.69±8.22 ng/ml, with a statistically significant difference (p=0.008, p=0.01 and p=0.012). Sleeve gastrectomy has proven to be an effective weight loss treatment. However, nutritional deficiencies have worsened during postoperative period. CONCLUSION: This study highlights the importance of early identification, appropriate treatment and prophylactic micronutrient supplementation.


Asunto(s)
Obesidad , Vitaminas , Adulto , Humanos , Vitaminas/uso terapéutico , Obesidad/complicaciones , Obesidad/epidemiología , Obesidad/cirugía , Vitamina D , Gastrectomía/efectos adversos , Pérdida de Peso
2.
Artículo en Inglés | MEDLINE | ID: mdl-28573216

RESUMEN

BACKGROUND: Diabetes mellitus is one of the most common endocrinal disorders and medicinal plants continue to play an important role in the management of this disease. In this study, Rosa canina was investigated for the antioxidant and α-amylase inhibition activities. MATERIALS AND METHODS: Methanolic extract of Rosa canina was investigated for its potential antioxidant activity. The extracts' total phenolic and flavonoid contents and scavenging capacity for free radicals were evaluated. The α-amylase inhibition assay was also carried. RESULTS: Rosa canina extract exhibits a total Phenolic and flavonoid levels respectively (21.918 mg GAE/g and 2.647mg ER/g). The free radical scavenging activity was found to be prominent against DPPH with an IC50 of 0.668 mg/ml and against ABTS with an IC50 of 0.467 mg/ml. Extract showed a significant ferric ion reducing activities with an IC50 of4.962 mg/ml. CONCLUSION: Rosa canina exerted a higher inhibitory activity against α-amylase. The obtained results support the antidiabetic use of rosa canina.


Asunto(s)
Amilasas/antagonistas & inhibidores , Antioxidantes/farmacología , Flavonoides/farmacología , Hipoglucemiantes/farmacología , Fenoles/farmacología , Extractos Vegetales/farmacología , Rosa/química , Benzotiazoles/metabolismo , Compuestos de Bifenilo/metabolismo , Diabetes Mellitus/enzimología , Flavonoides/análisis , Fenoles/análisis , Picratos/metabolismo , Extractos Vegetales/química , Ácidos Sulfónicos/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA